Contract award · 7 Apr 2023

Procurement of DAROLUTAMIDE TABLETS (NUBEQA) 300mg

Belfast Health and Social Care Trust awarded “Procurement of DAROLUTAMIDE TABLETS (NUBEQA) 300mg” to Bayer Plc for £140k. Awarded without open competition.

No competitionMedical equipment & pharmaceuticalsNorthern Ireland

Value £140k
WinnerBayer Plc

Awarded without open competition

Awarded without open competition. The buyer went directly to one or a few suppliers instead of advertising the contract. Procurement rules allow this only in specific cases, such as extreme urgency, when only one supplier can do the work, or for call-offs from an existing framework.

What “without competition” means

Key facts

Buyer
Belfast Health and Social Care Trust · Body governed by public law
Supplier
Bayer Plc
Value
£140,000
Procedure
Award procedure without prior publication of a call for competition
Sector
Medical equipment & pharmaceuticals · Medical equipments, pharmaceuticals and personal care products (CPV 33000000)
Timeline
  1. Contract date7 Apr 2023
  2. Published18 Apr 2023Published 11 days after the contract date

Description

Procurement of DAROLUTAMIDE TABLETS (NUBEQA) 300mg - Patent Protected Medicine

About the supplier

More from Belfast Health and Social Care Trust

All contracts

More won by Bayer Plc

All contracts

Recent medical equipment & pharmaceuticals contracts

Sector overview